Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Innovid Announces Fourth Quarter 2023 Financial Results and Provides Guidance for Full Year

Elaine Mendonca by Elaine Mendonca
February 27, 2024
in Breaking News
0
Technology Quantum computing Stock Exchange
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Innovid, a leading provider of connected TV advertising solutions, announced their financial results for the fourth quarter of 2023 on February 27, 2024. The company reported a GAAP EPS of $(0.01), which was in line with analyst expectations. This marked a 66.67% increase in losses compared to the same period last year when EPS was $(0.03) per share.

Quarterly sales for Innovid were $38.62 million, surpassing analyst estimates by 6.68%. This represented a 14.60% increase over sales of $33.70 million in the fourth quarter of the previous year.

Looking ahead, Innovid provided financial guidance for the fourth quarter and full year of 2023:

– Q4 2023 revenue is expected to fall between $35 million and $37 million.
– Adjusted EBITDA for Q4 2023 is projected to range from $5.5 million to $7.5 million.
– Full year 2023 revenue is anticipated to be within the range of $136 million and $138 million.
– Adjusted EBITDA for the full year 2023 is forecasted to be between $16.6 million and $18.6 million, with an Adjusted EBITDA margin.

Norwegian Cruise Line Holdings (NCLH) Stock Price Sees Slight Decrease on February 27, 2024 with Positive Pre-Market Momentum

On February 27, 2024, Norwegian Cruise Line Holdings (NCLH) experienced a slight decrease in its stock price. According to data from CNN Money, NCLH is currently trading in the middle of its 52-week range and below its 200-day simple moving average. The price of NCLH shares dropped by $0.24 since the market last closed, representing a 1.48% decrease. The stock closed at $15.93 on the previous trading day.

Despite the slight decrease in price, there seems to be some positive momentum for NCLH as the stock has risen by $1.46 in pre-market trading. This increase indicates that investors may be feeling more optimistic about the company’s future prospects.

NCLH Stock Surges with Impressive Financial Results in 2024

On February 27, 2024, Norwegian Cruise Line Holdings (NCLH) stock showed strong performances as the company reported impressive financial results. According to data from CNN Money, NCLH’s total revenue for the past year was $4.84 billion, which represents a significant increase of 647.51% compared to the previous year. Additionally, the total revenue for the third quarter of the fiscal year was $2.54 billion, showing a 14.99% increase since the previous quarter.

The company’s net income also saw substantial growth, with a net loss of $2.27 billion for the past year. However, this figure represents a 49.63% improvement compared to the previous year. In the third quarter, NCLH reported a net income of $345.87 million, marking an impressive 301.63% increase since the previous quarter.

Furthermore, NCLH’s earnings per share (EPS) showed positive growth trends, with an EPS of -$5.41 for the past year. This figure represents a 56.15% increase compared to the previous year. In the third quarter, the company reported an EPS of $0.68, reflecting a remarkable 261.94% increase since the previous quarter.

Overall, NCLH’s financial performance on February 27, 2024, indicates a positive trajectory for the company. Investors may view these strong financial results as a positive indicator of NCLH’s resilience and potential for growth in the future.

Tags: NCLH
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Pharmaceutical Markets and money

TG Therapeutics Granted Three New Patents for BRIUMVI in Treatment of Multiple Sclerosis

Title Appreciation for Minimum Postage Policy and Collaboration Standards

Biotechnology Markets and money

Verve Therapeutics Reports Impressive Q4 Financial Results

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com